However, the mechanisms underpinning Gi upregulation in chronic HF have remained unknown.10, 11β-Adrenergic antagonists (β-blockers) constitute a critical clinical advance in the treatment of HF, being able to improve cardiac output.12, 13. The gene discussed is GNAI1; the disease is hydrops fetalis.